Arcadia Biosciences, INC 8-K filings

NASDAQ

28 Mar 2024

RKDA

8-K: Arcadia Biosciences Reports Improved Financials and Strategic Progress in 2023

Arcadia Biosciences announced its fourth quarter and full year 2023 financial results, highlighting gross profit growth and reduced operating expenses.

NASDAQ

14 Feb 2024

RKDA

Arcadia Biosciences, INC

8-K: Arcadia Biosciences Announces Departure of Chief Marketing Officer and Approves Executive Retention Bonuses

Arcadia Biosciences has announced the resignation of its Chief Marketing Officer, Laura Pitlik, effective March 1, 2024, and approved retention bonuses for its CEO and CFO.